Sandbox/Alejandro: Difference between revisions

Jump to navigation Jump to search
Line 38: Line 38:
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5;" align=center | '''''Preferred Regimen'''''
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5;" align=center | '''''Preferred Regimen'''''
|-
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | ▸ '''''[[Meropenem]]'''''<br> OR <br> ▸ '''''[[Imipenem]]'''''<br> OR <br> ▸ ''''' [[Cefepime]] [[Ceftazidime]]'''''<br> OR <br> ▸ ''''' [[Piperacillin/tazobactam]]'''''
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | ▸ '''''[[Meropenem]] 0.5-1 g IV q8h (infuse over 15-30 min or in bolus over 3-5 min)'''''<br> OR <br> ▸ '''''[[Imipenem/cilastatin]] 1-2 g/day divided q6-8h (max: 50mg/kg/day)'''''<br> OR <br> ▸ '''''[[Cefepime]] 2g IV q8h'''''<br> OR <br> ▸ ''''' [[Piperacillin/tazobactam]] 12-18 g/day IV divided q4-6 h (maximum 24 g/day)'''''
|-
|-
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5;" align=center | '''''Alternative Regimen'''''
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5;" align=center | '''''Alternative Regimen 1 '''''
|-
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | aminoglycoside plus an antipseudomonal-penicillin or extended-spectrum cephalosporin
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | aminoglycoside
<br> OR <br> extended-spectrum penicillin and ciprofloxacin
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left |PLUS
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left |▸ '''''[[Cefepime]] 2g IV q8h'''''<br> OR <br> ▸ ''''' [[Piperacillin/tazobactam]] 12-18 g/day IV divided q4-6 h (maximum 24 g/day)'''''
|-
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5;" align=center | '''''Alternative Regimen 2 '''''
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left |▸ ''''' [[Piperacillin/tazobactam]] 12-18 g/day IV divided q4-6 h (maximum 24 g/day)'''''
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left |PLUS
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left |▸ ''''' [[Ciprofloxacin]] '''''
|-
|-
|}
|}

Revision as of 20:29, 4 June 2014

Neutropenic Patients

▸ Click on the following categories to expand treatment regimens.

Neutropenia

  ▸  Gram-Negative Bacteria

  ▸  Gram-Positive Bacteria

  ▸  Fungi


Gram-Negative Bacteria
Preferred Regimen
Meropenem 0.5-1 g IV q8h (infuse over 15-30 min or in bolus over 3-5 min)
OR
Imipenem/cilastatin 1-2 g/day divided q6-8h (max: 50mg/kg/day)
OR
Cefepime 2g IV q8h
OR
Piperacillin/tazobactam 12-18 g/day IV divided q4-6 h (maximum 24 g/day)
Alternative Regimen 1
aminoglycoside
PLUS
Cefepime 2g IV q8h
OR
Piperacillin/tazobactam 12-18 g/day IV divided q4-6 h (maximum 24 g/day)
Alternative Regimen 2
Piperacillin/tazobactam 12-18 g/day IV divided q4-6 h (maximum 24 g/day)
PLUS
Ciprofloxacin
Gram-Positive Bacteria
Preferred Regimen
Vancomycin 15-20 mg/kg IV q8-12h
Alternative Regimen
Linezolid 600 mg IV/PO q12h
OR
Daptomycin 4mg/kg IV q24h
Fungi
Preferred Regimen
Liposomal Amphotericin B 3 mg/kg/day IV × 1-2 weeks
OR
Amphotericin B deoxycholate 0.7-1 mg/kg/day IV × 1-2 weeks
OR
Amphotericin B lipid complex 5 mg/kg/day IV × 1-2 weeks
Alternative Regimen
Voriconazole 6 mg/kg IV q12h x 1 day, followed by 3 mg/kg IV or 200 mg PO q12h
OR
Caspofungin 70 mg IV once, then 50 mg IV q24h x ≥ 14 days

Cellular Immune Deficient Patients

Bacteria

  ▸  Nocardia spp

  ▸  Atypical mycobacteria

Fungi

  ▸  Cryptococcus spp

  ▸  Histoplasma spp

Viruses

  ▸  Varicella-zoster virus

  ▸  Herpes simplex virus

  ▸  Cytomegalovirus

Nocardia spp
Preferred Regimen
TMP-SMX x 3-12 months
Alternative Regimen 1
Sulfadiazine 2-4 g PO 1 dose
FOLLOWED BY
Sulfadiazine 2-4 g/day PO q4-8h x 3-12 months
Alternative Regimen 1
Imipenem 250-500 mg IV q6-8h x 3-12 months
Atypical mycobacteria
Preferred Regimen
[[
Alternative Regimen
[[
Cryptococcus spp
Preferred Regimen
Moderate Severe to Severe Disease
Liposomal Amphotericin B 3 mg/kg/day IV × 1-2 weeks
OR
Amphotericin B deoxycholate 0.7-1 mg/kg/day IV × 1-2 weeks
OR
Amphotericin B lipid complex 5 mg/kg/day IV × 1-2 weeks
FOLLOWED BY
Itraconazole 200 mg PO q12h x ≥12 months
Mild to Moderate Disease
Itraconazole 200 mg PO q12h x ≥12 months
Adapted from Clin Infect Dis. 2007;45(7):807-25.[1]
Histoplasma spp
Preferred Regimen
Liposomal Amphotericin B 3 mg/kg/day x 1- 2 weeks
OR

Amphotericin B lipid complex 5 mg/kg/day x 1- 2 weeks

FOLLOWED BY
Itraconazole 200mg q8h x 3 days
FOLLOWED BY
Itraconazole 200mg q12h x 6-12 months
Varicella-zoster virus
Preferred Regimen
Acyclovir 10-12 mg/kg IV (infusion over 1 hour) q8h x 7-10 days
Alternative Regimen
Famciclovir 500 mg PO x 7-10 days
OR
Valacyclovir 500 mg PO x 7-10 days
Herpes simplex virus
Preferred Regimen
Acyclovir 10 mg/kg IV (infusion over 1 hour) q8h x 7-10 days
Alternative Regimen
Famciclovir 500 mg PO x 7 days
OR
Valacyclovir 500 mg PO x 7 days
Cytomegalovirus
Preferred Regimen
Ganciclovir 5 mg/kg IV q12h x 21 days
Alternative Regimen
Valganciclovir 900 mg PO q12h x 21 days
  1. Wheat, LJ.; Freifeld, AG.; Kleiman, MB.; Baddley, JW.; McKinsey, DS.; Loyd, JE.; Kauffman, CA. (2007). "Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America". Clin Infect Dis. 45 (7): 807–25. doi:10.1086/521259. PMID 17806045. Unknown parameter |month= ignored (help)